P.M. Edition for Nov. 8. Some drugmakers are setting two prices for the same drug. And many health plans are choosing the more expensive version, according to data analysis conducted for the WSJ. Pharmaceutical reporter Peter Loftus explains why. Plus, three companies—including one run by a former NYSE president—are vying for collapsed cryptocurrency exchange FTX at auction. Markets reporter Vicky Ge Huang explains. Annmarie Fertoli hosts.

Learn more about your ad choices. Visit megaphone.fm/adchoices